Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis*

Objective:To evaluate protein C and other factors associated with the septic response as predictors of mortality in a clinically relevant animal model of sepsis. Design:Laboratory investigation. Setting:Eli Lilly and Company discovery research laboratory. Subjects:Forty female Sprague Dawley Rats weighing 245–265 g. Interventions:Polyethylene catheters were surgically implanted into the femoral vein and sepsis was induced by cecal ligation and puncture (CLP). A solution of 5% dextrose in 0.9% saline was continuously infused via femoral catheters immediately following surgery. Blood sampling was done before surgery and at 6 and 20 hrs after surgery. Rats were then monitored for survival out to 4 days. Measurements and Main Results:Blood collections were used to measure blood glucose, bacteremia, plasma protein C, D-dimer, hormones, chemokines, cytokines, and myoglobin (as a marker of organ damage). Mortality was categorized into three groups: early death (before 30 hrs post-CLP), late death (after 30 hrs post-CLP), and survivors (96 hrs post-CLP). Compared with survivors, early death rats had statistically significant differences in 30 variables indicative of severe inflammation, coagulopathy, and muscle damage including less bacterial clearance, hypoglycemia, lower plasma protein C, higher plasma D dimer, higher plasma cytokine/ chemokines, and higher plasma myoglobin concentrations. Twenty variables had a moderate to strong correlation with time of death. Receiver operator characteristic curves generated from a simple logistic regression model indicated that KC and macrophage inflammatory protein-2, rodent homologues of the human growth related oncogene CXC chemokine family, and protein C were the best predictors of mortality in this model. Conclusions:The data from this study indicate that an early decrease in protein C concentration predicts poor outcome in a rat sepsis model. The data further indicate that increases in the CXC chemokines macrophage inflammatory protein-2 and KC precede poor outcome.

[1]  R. L. Grubbs,et al.  Cecal ligation and puncture with total parenteral nutrition: a clinically relevant model of the metabolic, hormonal, and inflammatory dysfunction associated with critical illness. , 2004, The Journal of surgical research.

[2]  T. Iba,et al.  [Disseminated intravascular coagulation]. , 2003, Nihon rinsho. Japanese journal of clinical medicine.

[3]  R. Dellinger,et al.  Inflammation and coagulation: implications for the septic patient. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  K. Mace,et al.  Engineering the proteolytic specificity of activated protein C improves its pharmacological properties , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[6]  R. Hotchkiss,et al.  The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.

[7]  K. Ulm,et al.  DIFFERENTIAL REGULATION OF SYSTEMIC IL-18 AND IL-12 RELEASE DURING POSTOPERATIVE SEPSIS: HIGH SERUM IL-18 AS AN EARLY PREDICTIVE INDICATOR OF LETHAL OUTCOME , 2002, Shock.

[8]  T. Majima,et al.  Role of macrophage inflammatory protein 2 in acute lung injury in murine peritonitis. , 2002, The Journal of surgical research.

[9]  J. Helterbrand,et al.  Low levels of protein C are associated with poor outcome in severe sepsis. , 2001, Chest.

[10]  C. Esmon,et al.  Dysfunction of endothelial protein C activation in severe meningococcal sepsis. , 2001, The New England journal of medicine.

[11]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[12]  J Ean,et al.  Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[13]  C. Fisher,et al.  Protein C levels as a prognostic indicator of outcome in sepsis and related diseases , 2000, Critical care medicine.

[14]  I. Chaudry,et al.  Immune depression in polymicrobial sepsis: The role of necrotic (injured) tissue and endotoxin , 2000, Critical care medicine.

[15]  José A Fernández,et al.  Prognostic value of protein C concentrations in neutropenic patients at high risk of severe septic complications , 2000, Critical care medicine.

[16]  B. Bistrian,et al.  Metabolic effects of insulin and insulin-like growth factor-I in endotoxemic rats during total parenteral nutrition feeding. , 2000, Metabolism: clinical and experimental.

[17]  R. Balk.  SEVERE SEPSIS AND SEPTIC SHOCK Definitions, Epidemiology, and Clinical Manifestations , 2000 .

[18]  N. Clausell,et al.  Circulating endothelin-1 and tumor necrosis factor-α: early predictors of mortality in patients with septic shock , 2000, Intensive Care Medicine.

[19]  S. Deventer,et al.  Prognostic value of cytokine concentrations (tumor necrosis factor-alpha, interleukin-6, and interleukin-10) and clinical parameters in severe melioidosis. , 2000, The Journal of infectious diseases.

[20]  E. Abraham,et al.  Why immunomodulatory therapies have not worked in sepsis , 1999, Intensive Care Medicine.

[21]  K. Reinhart,et al.  Outcome Prediction by Traditional and New Markers of Inflammation in Patients with Sepsis , 1999, Clinical chemistry and laboratory medicine.

[22]  C. Esmon,et al.  Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes. , 1998, Blood.

[23]  K. Shaffer,et al.  Radiologic evaluation in lung cancer: diagnosis and staging. , 1997, Chest.

[24]  T. Standiford,et al.  Elevated levels of macrophage inflammatory protein 2 in severe murine peritonitis increase neutrophil recruitment and mortality , 1997, Infection and immunity.

[25]  R. Bone,et al.  Sepsis: a new hypothesis for pathogenesis of the disease process. , 1997, Chest.

[26]  T. van der Poll,et al.  Effect of a recombinant dimeric tumor necrosis factor receptor on inflammatory responses to intravenous endotoxin in normal humans. , 1997, Blood.

[27]  M. Lamy,et al.  Sepsis and serum cytokine concentrations. , 1997, Critical care medicine.

[28]  P. Mannucci,et al.  Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. , 1996, Blood.

[29]  S. Alfieri,et al.  Prognosis in intra-abdominal infections. Multivariate analysis on 604 patients. , 1996, Archives of surgery.

[30]  J. Vincent,et al.  Blood lactate levels are better prognostic indicators than TNF and IL-6 levels in patients with septic shock , 1996, Intensive Care Medicine.

[31]  R. Auckenthaler,et al.  Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. , 1996, American journal of respiratory and critical care medicine.

[32]  S. Nasraway,et al.  Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. , 1995, JAMA.

[33]  G. Koch,et al.  Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome: A Randomized, Controlled, Double-blind, Multicenter Clinical Trial , 1995 .

[34]  S. Opal,et al.  Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. , 1994, JAMA.

[35]  R. F. Johnston,et al.  Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial , 1994 .

[36]  G Görög,et al.  An Excel program for calculating and plotting receiver-operator characteristic (ROC) curves, histograms and descriptive statistics. , 1994, Computers in biology and medicine.

[37]  D. Powars,et al.  Epidemic meningococcemia and purpura fulminans with induced protein C deficiency. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  D. Pittet,et al.  Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients , 1993, Intensive Care Medicine.

[39]  M. McManus,et al.  Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura , 1993, Critical care medicine.

[40]  J. Lorente,et al.  clinical investigations in critical care Time Course of Hemostatic Abnormalities in Sepsis and its Relation to Outcome * , 2006 .

[41]  C. Chopin,et al.  Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. , 1992, Chest.

[42]  M. Blombäck,et al.  Protein C, Protein S and c4b-Binding Protein in Severe lnfection and Septic Shock , 1991, Thrombosis and Haemostasis.

[43]  F. Cerra,et al.  Multiple organ failure syndrome. , 1990, Disease-a-month : DM.

[44]  M. Nettleman,et al.  Receiver Operator Characteristic (ROC) Curves , 1988, Infection Control & Hospital Epidemiology.

[45]  Christine M. Miller,et al.  Serial Studies of Protein C and Its Plasma Inhibitor in Patients With , 1985 .

[46]  K. Kario,et al.  Fibrin D-dimer in thrombogenic disorders. , 2000, Seminars in thrombosis and hemostasis.

[47]  T. Koyama,et al.  Plasma Levels of Endothelial Cell Protein C Receptor Are Elevated in Patients With Sepsis and Systemic Lupus Erythematosus : Lack of Correlation With Thrombomodulin Suggests Involvement of Different Pathological Processes , 1998 .

[48]  J. T. ten Cate,et al.  Coagulation Activation and Tissue Necrosis in Meningococcal Septic Shock: Severely Reduced Protein C Levels Predict a High Mortality , 1995, Thrombosis and Haemostasis.

[49]  J. Román,et al.  Protein C, protein S and C4b-binding protein in neonatal severe infection and septic shock , 1992, Journal of perinatal medicine.